Search

Amanda Marie Haney

Examiner (ID: 4279, Phone: (571)272-8668 , Office: P/1634 )

Most Active Art Unit
1634
Art Unit(s)
1634, 1682
Total Applications
1000
Issued Applications
285
Pending Applications
140
Abandoned Applications
613

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18666578 [patent_doc_number] => 11773456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => Loop-mediated isothermal amplification (LAMP) primer sets for detecting porcine susceptibility-related pathogenic bacteria, and kit, LAMP chip and use based on the same [patent_app_type] => utility [patent_app_number] => 17/820601 [patent_app_country] => US [patent_app_date] => 2022-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 7293 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 575 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820601 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/820601
Loop-mediated isothermal amplification (LAMP) primer sets for detecting porcine susceptibility-related pathogenic bacteria, and kit, LAMP chip and use based on the same Aug 17, 2022 Issued
Array ( [id] => 18511727 [patent_doc_number] => 20230227914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => BIOMARKERS OF ORAL, PHARYNGEAL AND LARYNGEAL CANCERS [patent_app_type] => utility [patent_app_number] => 17/888290 [patent_app_country] => US [patent_app_date] => 2022-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888290 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/888290
BIOMARKERS OF ORAL, PHARYNGEAL AND LARYNGEAL CANCERS Aug 14, 2022 Abandoned
Array ( [id] => 18093514 [patent_doc_number] => 20220411855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => PORTABLE, LOW-COST PATHOGEN DETECTION AND STRAIN IDENTIFICATION PLATFORM [patent_app_type] => utility [patent_app_number] => 17/849250 [patent_app_country] => US [patent_app_date] => 2022-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25521 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849250 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/849250
Portable, low-cost pathogen detection and strain identification platform Jun 23, 2022 Issued
Array ( [id] => 19210954 [patent_doc_number] => 12000004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-04 [patent_title] => Methods for molecularly characterizing cervical cell samples [patent_app_type] => utility [patent_app_number] => 17/839803 [patent_app_country] => US [patent_app_date] => 2022-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 12693 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839803 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/839803
Methods for molecularly characterizing cervical cell samples Jun 13, 2022 Issued
Array ( [id] => 17883079 [patent_doc_number] => 20220298556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => PIRNA-54265 DETECTION KIT USED FOR EARLY SCREENING, DIAGNOSIS, CURATIVE EFFICACY MONITORING AND PROGNOSTIC EVALUATION OF COLORECTAL CANCER [patent_app_type] => utility [patent_app_number] => 17/830354 [patent_app_country] => US [patent_app_date] => 2022-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10533 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830354 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/830354
PIRNA-54265 detection kit used for early screening, diagnosis, curative efficacy monitoring and prognostic evaluation of colorectal cancer Jun 1, 2022 Issued
Array ( [id] => 17838158 [patent_doc_number] => 20220275463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => STRATIFICATION AND PROGNOSIS OF CANCER [patent_app_type] => utility [patent_app_number] => 17/751038 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17735 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751038 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/751038
STRATIFICATION AND PROGNOSIS OF CANCER May 22, 2022 Abandoned
Array ( [id] => 18909267 [patent_doc_number] => 11872230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-16 [patent_title] => Method of treating a methionine-dependent cancer [patent_app_type] => utility [patent_app_number] => 17/745292 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 22701 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745292 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/745292
Method of treating a methionine-dependent cancer May 15, 2022 Issued
Array ( [id] => 17838929 [patent_doc_number] => 20220276234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => POINT-OF-CARE IMMUNOASSAY FOR QUANTITATIVE SMALL ANALYTE DETECTION [patent_app_type] => utility [patent_app_number] => 17/739731 [patent_app_country] => US [patent_app_date] => 2022-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739731 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/739731
POINT-OF-CARE IMMUNOASSAY FOR QUANTITATIVE SMALL ANALYTE DETECTION May 8, 2022 Pending
Array ( [id] => 17990484 [patent_doc_number] => 20220356521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => METHODS FOR DETECTING, MONITORING, AND GUIDING TREATMENT OF ALLOGRAFT REJECTION USING DISCRIMINATING GENE EXPRESSION SIGNATURES [patent_app_type] => utility [patent_app_number] => 17/733762 [patent_app_country] => US [patent_app_date] => 2022-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17733762 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/733762
METHODS FOR DETECTING, MONITORING, AND GUIDING TREATMENT OF ALLOGRAFT REJECTION USING DISCRIMINATING GENE EXPRESSION SIGNATURES Apr 28, 2022 Pending
Array ( [id] => 18764301 [patent_doc_number] => 11814688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-14 [patent_title] => Markers for determining tumor hypoxia [patent_app_type] => utility [patent_app_number] => 17/728506 [patent_app_country] => US [patent_app_date] => 2022-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 15 [patent_no_of_words] => 19739 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728506 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/728506
Markers for determining tumor hypoxia Apr 24, 2022 Issued
Array ( [id] => 17990493 [patent_doc_number] => 20220356530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => METHODS FOR DETERMINING VELOCITY OF TUMOR GROWTH [patent_app_type] => utility [patent_app_number] => 17/725341 [patent_app_country] => US [patent_app_date] => 2022-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82982 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725341 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/725341
METHODS FOR DETERMINING VELOCITY OF TUMOR GROWTH Apr 19, 2022 Pending
Array ( [id] => 17830558 [patent_doc_number] => 20220267862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => DNA METHYLATION SIGNATURES OF CANCER IN HOST PERIPHERAL BLOOD MONONUCLEAR CELLS AND T CELLS [patent_app_type] => utility [patent_app_number] => 17/700702 [patent_app_country] => US [patent_app_date] => 2022-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 416 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700702 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/700702
DNA METHYLATION SIGNATURES OF CANCER IN HOST PERIPHERAL BLOOD MONONUCLEAR CELLS AND T CELLS Mar 21, 2022 Pending
Array ( [id] => 20173251 [patent_doc_number] => 12391985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-19 [patent_title] => Method of determining [patent_app_type] => utility [patent_app_number] => 17/699761 [patent_app_country] => US [patent_app_date] => 2022-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 8892 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699761 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/699761
Method of determining Mar 20, 2022 Issued
Array ( [id] => 18077855 [patent_doc_number] => 20220403467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => DETERMINING CELL TYPE ORIGIN OF CIRCULATING CELL-FREE DNA WITH MOLECULAR COUNTING [patent_app_type] => utility [patent_app_number] => 17/682759 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3119 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682759 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/682759
DETERMINING CELL TYPE ORIGIN OF CIRCULATING CELL-FREE DNA WITH MOLECULAR COUNTING Feb 27, 2022 Pending
Array ( [id] => 17735923 [patent_doc_number] => 20220221382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => METHOD OF POOLING BLOOD SAMPLES [patent_app_type] => utility [patent_app_number] => 17/652172 [patent_app_country] => US [patent_app_date] => 2022-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17652172 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/652172
METHOD OF POOLING BLOOD SAMPLES Feb 22, 2022 Pending
Array ( [id] => 17830556 [patent_doc_number] => 20220267860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => LONGITUDINAL MOLECULAR DIAGNOSTICS DETECT SOMATIC REVERSION MUTATIONS [patent_app_type] => utility [patent_app_number] => 17/651793 [patent_app_country] => US [patent_app_date] => 2022-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12332 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651793 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/651793
LONGITUDINAL MOLECULAR DIAGNOSTICS DETECT SOMATIC REVERSION MUTATIONS Feb 18, 2022 Abandoned
Array ( [id] => 17750872 [patent_doc_number] => 20220229077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS [patent_app_type] => utility [patent_app_number] => 17/651397 [patent_app_country] => US [patent_app_date] => 2022-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38982 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651397 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/651397
DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS Feb 15, 2022 Abandoned
Array ( [id] => 19210943 [patent_doc_number] => 11999993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-04 [patent_title] => Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitor [patent_app_type] => utility [patent_app_number] => 17/669008 [patent_app_country] => US [patent_app_date] => 2022-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10641 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669008 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/669008
Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitor Feb 9, 2022 Issued
Array ( [id] => 17792562 [patent_doc_number] => 20220251653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => Determining Antigen-Specific T-Cells [patent_app_type] => utility [patent_app_number] => 17/579900 [patent_app_country] => US [patent_app_date] => 2022-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579900 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/579900
Determining antigen-specific T-cells Jan 19, 2022 Issued
Array ( [id] => 18844986 [patent_doc_number] => 20230407390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => NUCLEIC ACID AMPLIFICATION METHOD, PRIMER SET, PROBE, AND KIT FOR NUCLEIC ACID AMPLIFICATION METHOD [patent_app_type] => utility [patent_app_number] => 18/036524 [patent_app_country] => US [patent_app_date] => 2021-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14647 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 366 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036524 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/036524
NUCLEIC ACID AMPLIFICATION METHOD, PRIMER SET, PROBE, AND KIT FOR NUCLEIC ACID AMPLIFICATION METHOD Dec 23, 2021 Pending
Menu